Single centre, open-label, intra-individual, comparison, proof of concept study to determine the efficacy of an artemether topical formulation in subjects with seborrheic keratosis
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Artemether (Primary)
- Indications Seborrhoeic keratosis
- Focus Proof of concept; Therapeutic Use
- Sponsors EpiPharm AG
- 24 Jul 2015 Status changed from active, no longer recruiting to completed as per ISRCTN: Current Controlled Trials record.
- 03 Mar 2015 New trial record
- 24 Feb 2015 Status changed from recruiting to active, no longer recruiting as per ISRCTN record.